International CIPN Assessment and Validation Study (ICAVS)

NCT04633655

PATENTS

Tumor Agnostic Drug Delivery with Self-Agglomerating Nanohydrogels

Housley et al.

Application No. PCT/US2024/040745

Combination Therapeutics for Treatment of Proliferative Disorders

Housley et al.

Application No. 18/271,926

Inline Manipulation of Cells and Cell Clusters

Boya et al.

Application No. PCT/US2023/082980

Start Ups

OnCuRNA

At OnCuRNA, our novel nanohydrogel system (SANGs) enhances the delivery of therapeutic payloads to solid tumors, offering unprecedented control over drug release, targeting, and efficacy.

https://oncurna.com

Have Questions?

Shoot us an email! We love to talk science.